iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $50K invested in iPath Pure Beta Lead ETN in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
2% more capital invested
Capital invested by funds: $49K → $50K (+$1K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.15K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $46K | +$3.15K | +95 | +7% |
|
2
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
LEDD Hedge Fund Activity: Q2 2015 in Review
2 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q2 2015, worth a combined $50K — up 2% from $49K a quarter earlier.
Fund positioning in LEDD was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $3.15K.
- 2 institutional investors held iPath Pure Beta Lead ETN (LEDD) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $50K of iPath Pure Beta Lead ETN stock for Q2 2015, up 2% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Lead ETN positions in Q2 2015 and 0 closed out.
- The largest iPath Pure Beta Lead ETN buyer in Q2 2015 was UBS Group, an estimated $3.15K added.
Based on aggregated 13F filings for Q2 2015.